BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 25719388)

  • 1. Epigenetic biomarkers in the blood of patients with urological malignancies.
    Ellinger J; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Progress of Epigenetic Biomarkers in Urological Cancer.
    Wu P; Cao Z; Wu S
    Dis Markers; 2016; 2016():9864047. PubMed ID: 27594736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 5. Epigenetic biomarkers in urological tumors: A systematic review.
    Jerónimo C; Henrique R
    Cancer Lett; 2014 Jan; 342(2):264-74. PubMed ID: 22198482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.
    Angulo JC; López JI; Ropero S
    Mol Diagn Ther; 2016 Dec; 20(6):531-549. PubMed ID: 27501813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic epigenetic biomarkers in cancer.
    Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
    Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies.
    Larsen LK; Lind GE; Guldberg P; Dahl C
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biomarkers for the identification and targeted therapy of gastric cancer.
    Liu L; Cao L; Gong B; Yu J
    Expert Rev Gastroenterol Hepatol; 2015; 9(9):1217-26. PubMed ID: 26220043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.
    Ralla B; Stephan C; Meller S; Dietrich D; Kristiansen G; Jung K
    Crit Rev Clin Lab Sci; 2014 Aug; 51(4):200-31. PubMed ID: 24878357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of methylation in urological tumours.
    van der Heijden AG
    Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.
    Hosseinalizadeh H; Mahmoodpour M; Ebrahimi A
    Mol Biol Rep; 2022 Jan; 49(1):705-715. PubMed ID: 34677714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of Urological Cancers.
    Schulz WA; Sørensen KD
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer.
    De Leeneer K; Claes K
    Adv Exp Med Biol; 2015; 867():263-75. PubMed ID: 26530371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA alterations in body fluids as molecular tumor markers for urological malignancies.
    Goessl C; Müller M; Straub B; Miller K
    Eur Urol; 2002 Jun; 41(6):668-76. PubMed ID: 12074786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: a novel non-invasive biomarker for patients with urological malignancies.
    Ellinger J; Muller SC
    Curr Pharm Biotechnol; 2014; 15(5):486-91. PubMed ID: 24846060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.